Intervene With Jakafi® (ruxolitinib) at the First Sign of Initial Systemic Treatment Failure in Chronic GVHD: A Real-World, Case-Based Discussion

Date: January 24, 2023

Time: 03:00PM - 04:00PM

You must be registered to participate!

Speakers:

• Linda Perry, MS, PA-C, University of Pennsylvania/Abramson Cancer Center